The Committee for Medicinal Products for Human Use (CHMP) has refused, a second time, to approve the gene therapy product...
uniQure announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion...
Cached in a SEC filing (9 April), but not referred to in press releases, is a summary of a EMA...
uniQure N.V. announced that it will not pursue the renewal of the Glybera(alipogene tiparvovec) marketing authorization in Europe when it...